Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

06.09.21

Population Pharmacokinetic Modelling and Simulation of Imeglimin in Type 2 Diabetes Patients to Support Dose Recommendations to Patients with Renal Impairment

MIDD

Endocrinology

Specific populations

Pharmacometrics

Metabolism

Renal diseases

PAGE 29 (2021) Abstr 9668.

Mezzalana E, Tomita Y, Hansson E, Mazuir F, Wellhagen G, Ooi QX, Kitamura A, Nemoto D, Bolze S

01.09.21

Comparison of Quality of Urinary Bladder Filling in CT Urography with Different Doses of Furosemide in the Work-Up of Patients with Macroscopic Hematuria

Oncology

Radiography (Lond). 2021 Feb;27(1):136-141.

Ljungberg A, Segelsjö M, Dahlman P, Helenius M, Magnusson MO, Magnusson A

21.07.21

Exposure-Response Analysis of Etrolizumab in Patients with Moderately-to-severely Active Ulcerative Colitis

Pharmacometrics

Gastroenterology

ACoP12 (Nov 2021) PMX-82.

Kassir N, Zhu R, Moein A, Langenhorst J, Ribbing J, Zhang R, Tang M, Oh YS, Zhang W

01.05.21

[2] A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol and Caffeine

PBPK & PBBM

PAGE 29 (2021) Abstr 9603.

Kanacher T, Michon I, Lindauer A, Mezzalana E, Dansirikul C, Veau C, Mantilla JDG, Nock V, Fleury A.

01.04.21

Enhancing Efficiency and Decision Quality in Parkinson’s Disease Drug Trials for LRRK2 Programs Using Item Response Modelling

MIDD

Trial design and analysis

Pharmacometrics

CNS

PAGE 29 (2021) Abstr 9857.

Ibrahim MMA, Plan EL, Jönsson S, Chen C, Karlsson MO

01.04.21

Building Model-Informed Precision Dosing Software Using R: Blueprint for a State-of-the-Art Development Process

PAGE 29 (2021) Abstr 9747.

Faelens R, Luyckx N, Leirens Q, Bouillon T, Kuypers D, Annaert P

27.02.21

Population Pharmacokinetic/Pharmacodynamic Modelling of the Psychedelic Experience Induced by N,N-dimethyltryptamine

Pharmacometrics

CNS

PAGE 29 (2021) Abstr 9767.

Eckernäs E, Timmermann C, Röshammar D, Ashton M

02.02.21

Population Pharmacokinetic and Exposure-Response Models for Dapirolizumab Pegol in Patients with Systemic Lupus Erythematosus

Immunology

Pharmacometrics

PAGE 29 (2021) Abstr 9884.

Acharya C, Magnusson MO, Vajjah P, Zamacona M

1 …242526… 34

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Science & Services
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Copyright © Pharmetheus AB 2026

Whistleblower
Privacy Policy
Cookie Policy